GeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo
Titel:
GeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo
Auteur:
Loibl, S. Jackisch, C. Rastogi, P. Seiler, S. Lucas, P.C. Denkert, C. Costantino, J. Nekljudova, V. Wolmark, N. Geyer, C.